HD-NE02

N/A

Report date: 2025/10/24 17:59:44

Base Information

Drug NameHD-NE02
Drug Alias NameHD-NE02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y2 agonists
TargetsPurinergic receptor P2Y2
Therapy Area/IndicationsXerophthalmiaConjunctival DiseasesCorneal Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNanjing H&D Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing H&D Pharmaceutical Technology Co LtdJiangsu Dahongying Hengshun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsXerophthalmiaConjunctival DiseasesCorneal Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A